AGs Across the U.S. Call on Congress to Address Drug Price Gouging by Corrupt Pharma Middlemen
Missouri AG Bailey leads a coalition of 39 attorneys general urging Congress to restrict PBMs from owning pharmacies to reduce drug prices.
AstraZeneca rejoins leading U.S. drug lobby group after two-year absence
AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and Manufacturers of America (PhRMA) said on Tuesday.
Roche, Regeneron Announce Combined $56B Expansions As Tariffs Loom
Swiss drugmaker Roche will spend $50B to expand its U.S. manufacturing, while New York-based Regeneron will spend more than $6B to grow its operations.
Roche plans $50B expansion in US, including NJ, as drugmakers grapple with Trump tariffs
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded” U.S facilities
These companies say they’re investing more in U.S. manufacturing as tariffs go into effect
President Trump wants to bring manufacturing back to the U.S. These companies say they’re investing in domestic factories.
An ‘insane’ calculus: A pharma company raised price for a rare disease drug 150% to cover Medicaid rebates
A pharma company raised the price for a rare disease drug by 150%, arguing a new U.S. law left it no other choice.
Regeneron to invest over $3 billion to boost US manufacturing
Regeneron Pharmaceuticals said on Tuesday it had entered into a deal valued at more than $3 billion with contract drug developer Fujifilm Diosynth to expand its U.S. manufacturing capacity.
Patient Inclusivity: The Missing Piece In Pharma’s Global Innovation Strategy
The pharmaceutical industry’s next billion-dollar blockbuster won’t come from a lab alone—it will come from listening to patients.
Why Trump’s pharma tariffs are a political minefield
The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry and outside experts are raising red flags over worsening shortages and
Fractal Forest Methylene Blue: Pharmaceutical-Grade Ingredients to Support Mitochondrial health
Fractal Forest Methylene Blue is used to support mitochondrial health, boost ATP production, reduce oxidative stress, and enhance cognitive performance. It is especially popular among those seeking a pharmaceutical-grade methylene blue supplement for brain fog, energy depletion, and cellular longevity.